BETY program after knee injections for osteoarthritis
Part of Brain & nervous system, Pain clinical trials.
This trial tests if a special exercise and education program called BETY helps people with knee osteoarthritis feel better after getting a knee injection. You may qualify if you had a knee injection in the last month and have moderate knee arthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have knee osteoarthritis diagnosed by a doctor
- Your knee arthritis is moderate (stage 2 or 3 on an X-ray scale)
- You received a knee injection in the past month
- You are 18 years or older
- You can read and write
- You have not had knee surgery or a serious knee injury in the last 6 months
- You have not done physical therapy for your knee in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different exercise programs to see which one better improves knee cartilage thickness and reduces pain in people with knee osteoarthritis. It may help you find a safe, effective way to manage your symptoms at home.
This study tests a special, computer-guided lower-limb exercise program to reduce knee pain and improve how well you can move. It is designed for people with frequent knee pain and x-ray confirmed knee osteoarthritis.
This study compares a movement therapy called Basic Body Awareness Therapy to usual care for people with knee osteoarthritis. It aims to see if this therapy can improve pain, movement, and quality of life.
This study looks at how biological, psychological, and social factors affect people with knee osteoarthritis. It may help researchers better understand your condition and find better ways to support you.
This trial tests if learning about chronic pain can help people with knee osteoarthritis feel better. You'll join a program that teaches you about pain and how to manage it.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.